Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neurocrine Biosciences
Biotech
Biogen R&D vet gets in Formation—Chutes & Ladders
Biogen R&D vet gets in Formation. Verdiva adds experienced obesity leader as CMO. Sanofi refreshes executive committee.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
,
Marissa Russo
Jul 24, 2026 8:30am
Eric Topol boards Flagship as advisor—Chutes & Ladders
Mar 20, 2026 8:30am
Midsize biotechs form coalition to fight against MFN policy
Feb 25, 2026 1:05pm
Neurocrine-Takeda psychiatry pact suffers another phase 2 fail
Nov 11, 2025 6:25am
Neurocrine pens $880M pact with TransThera for immunology target
Nov 3, 2025 5:42am
Sanofi vaccine vet vaults to GSK—Chutes & Ladders
Jun 13, 2025 8:30am